Free Trial
OTCMKTS:EMMA

Emmaus Life Sciences (EMMA) Stock Price, News & Analysis

Emmaus Life Sciences logo
$0.01 0.00 (-9.17%)
As of 08/29/2025 02:25 PM Eastern

About Emmaus Life Sciences Stock (OTCMKTS:EMMA)

Key Stats

Today's Range
$0.0109
$0.0110
50-Day Range
$0.0109
$0.0160
52-Week Range
$0.00
$0.05
Volume
323,580 shs
Average Volume
29,742 shs
Market Capitalization
$696.18 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EMMA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EMMA Stock News Headlines

The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”tc pixel
Emmaus Life Sciences Inc
See More Headlines

EMMA Stock Analysis - Frequently Asked Questions

Emmaus Life Sciences' stock was trading at $0.0085 at the start of the year. Since then, EMMA stock has increased by 28.2% and is now trading at $0.0109.

Emmaus Life Sciences, Inc. (OTCMKTS:EMMA) released its earnings results on Thursday, August, 14th. The company reported ($0.02) EPS for the quarter. The firm had revenue of $2.82 million for the quarter.

Shares of EMMA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Emmaus Life Sciences investors own include Humanigen (HGEN), Fulcrum Therapeutics (FULC), Sorrento Therapeutics (SRNE), Acasti Pharma (ACST), Actinium Pharmaceuticals (ATNM) and Entasis Therapeutics (ETTX).

Company Calendar

Last Earnings
8/14/2025
Today
8/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:EMMA
CIK
822370
Employees
60
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.45 million
Net Margins
-24.20%
Pretax Margin
-28.35%
Return on Equity
N/A
Return on Assets
-14.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.08
Quick Ratio
0.06

Sales & Book Value

Annual Sales
$16.65 million
Price / Sales
0.04
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.87) per share
Price / Book
-0.01

Miscellaneous

Outstanding Shares
63,870,000
Free Float
41,513,000
Market Cap
$696.18 thousand
Optionable
Not Optionable
Beta
8.03

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:EMMA) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners